Takatsuki, Japan

Yoichi Iguchi


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 22(Granted Patents)


Location History:

  • Takatsuki, JP (1982)
  • Kusatsu, JP (1983)

Company Filing History:


Years Active: 1982-1983

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yoichi Iguchi: Innovator in Pharmaceutical Chemistry

Introduction

Yoichi Iguchi is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to drug design.

Latest Patents

Iguchi holds 2 patents that focus on groundbreaking pharmaceutical compounds. His latest patents include prostacyclin analogues and 1-substituted imidazole derivatives. The prostacyclin analogues are designed to possess selective strong stimulatory activity on uterine contraction in female mammals. The 1-substituted imidazole derivatives exhibit a strong inhibitory effect on thromboxane synthetase, making them useful for treating inflammation, hypertension, thrombus, cerebral apoplexy, and asthma.

Career Highlights

Throughout his career, Iguchi has worked with notable companies such as Ono Pharmaceutical Co., Ltd. and Kissei Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Iguchi has collaborated with esteemed colleagues, including Masaki Hayashi and Hirohisa Wakatsuka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yoichi Iguchi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to impact the development of therapeutic agents that address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…